ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer-Reference-Cited by-同舟云学术

ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer

Published:2024-05 Issue:5 Volume:9 Page:102992
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Carrera P.M.,Curigliano G.,Santini D.,Sharp L.^ORCID,Chan R.J.^ORCID,Pisu M.,Perrone F.^ORCID,Karjalainen S.,Numico G.^ORCID,Cherny N.^ORCID,Winkler E.,Amador M.L.,Fitch M.,Lawler M.,Meunier F.,Khera N.^ORCID,Pentheroudakis G.^ORCID,Trapani D.,Ripamonti C.I.^ORCID

Funder

Medtronic

Publisher

Elsevier BV

Reference121 articles.

1. Cancer treatment and survivorship statistics, 2022;Miller;CA Cancer J Clin,2022

2. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers;Dyba;Eur J Cancer,2021

3. A comprehensive assessment of universal health coverage in 111 countries: a retrospective observational study;Wagstaff;Lancet Glob Health,2020

4. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment;Carrera;CA Cancer J Clin,2018

5. Financial toxicity;Carrera,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Earnings and work loss after colon and rectal cancer: a Swedish nationwide matched cohort study;eClinicalMedicine;2024-09

2. Total pain, opioids, and immune checkpoint inhibitors in the survival of patients with cancer;ESMO Open;2024-09

3. CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harms;European Journal of Cancer;2024-08